In multivariate survival analysis, EGFR (p = 0.023), patients' age (p<0.001), Dukes' stage (p<0.001), tumour location (p = 0.001), and WHO grade (p = 0.033) were independent prognostic factors (Table 4). This evidence concerns the gene EGFR and neoplasm.